These data collectively support that combinatorial antibiotic treatment mediated COX-2 inhibition or strategies that disrupt prostaglandin signaling pathways as useful adjunctive therapies in treating persistent and multi-drug resistant infection. This evidence concerns the gene PTGS2 and infection.